News|Articles|August 2, 2015

Pharmaceutical Technology

  • Pharmaceutical Technology-08-02-2015
  • Volume 39
  • Issue 8

Syringe Closure System Allows Use of Highly Sensitive Compounds

Vetter’s Vetter-Ject closure system for prefilled syringes has an integrated needle hub and shield and is designed for sensitive compounds, such as biologics.

Vetter’s Vetter-Ject closure system for prefilled syringes has an integrated needle hub and shield and is designed for sensitive compounds, such as biologics. The system’s baked-in siliconization process for the glass barrel allows the silicon content to be customized. The percentage of silicon used can be reduced up to 80% compared to standard siliconization processes used in conventional syringe systems, which makes the system suitable for silicon-sensitive drug products. The closure is tamper-evident; plastic bridges are broken when the needle shield is removed. The system can be used with a wide range of primary packaging options, such as stoppers and glass barrels.

Vetter Pharma International GmbH
www.vetter-pharma.com

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.